160 related articles for article (PubMed ID: 17971198)
1. Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.
Tesei A; Rosetti M; Ulivi P; Fabbri F; Medri L; Vannini I; Bolla M; Amadori D; Zoli W
J Transl Med; 2007 Oct; 5():52. PubMed ID: 17971198
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.
Leonetti C; Scarsella M; Zupi G; Zoli W; Amadori D; Medri L; Fabbri F; Rosetti M; Ulivi P; Cecconetto L; Bolla M; Tesei A
Mol Cancer Ther; 2006 Apr; 5(4):919-26. PubMed ID: 16648562
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines.
Tesei A; Ulivi P; Fabbri F; Rosetti M; Leonetti C; Scarsella M; Zupi G; Amadori D; Bolla M; Zoli W
J Transl Med; 2005 Feb; 3(1):7. PubMed ID: 15691389
[TBL] [Abstract][Full Text] [Related]
4. NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells.
Tesei A; Zoli W; Fabbri F; Leonetti C; Rosetti M; Bolla M; Amadori D; Silvestrini R
Nitric Oxide; 2008 Sep; 19(2):225-36. PubMed ID: 18472019
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells.
Fabbri F; Brigliadori G; Ulivi P; Tesei A; Vannini I; Rosetti M; Bravaccini S; Amadori D; Bolla M; Zoli W
Apoptosis; 2005 Oct; 10(5):1095-103. PubMed ID: 16151642
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.
Rosetti M; Tesei A; Ulivi P; Fabbri F; Vannini I; Brigliadori G; Amadori D; Bolla M; Zoli W
Apoptosis; 2006 Aug; 11(8):1321-30. PubMed ID: 16699954
[TBL] [Abstract][Full Text] [Related]
7. NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.
Tesei A; Ricotti L; Ulivi P; Medri L; Amadori D; Zoli W
Int J Oncol; 2003 Jun; 22(6):1297-302. PubMed ID: 12738997
[TBL] [Abstract][Full Text] [Related]
8. NCX 4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of I kappa B-alpha degradation in human monocytes.
Ricciotti E; Dovizio M; Di Francesco L; Anzellotti P; Salvatore T; Di Francesco A; Sciulli MG; Pistritto G; Monopoli A; Patrignani P
J Immunol; 2010 Feb; 184(4):2140-7. PubMed ID: 20065114
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
Fiorucci S; Antonelli E; Santucci L; Morelli O; Miglietti M; Federici B; Mannucci R; Del Soldato P; Morelli A
Gastroenterology; 1999 May; 116(5):1089-106. PubMed ID: 10220501
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3.
Royle JS; Ross JA; Ansell I; Bollina P; Tulloch DN; Habib FK
J Urol; 2004 Jul; 172(1):338-44. PubMed ID: 15201807
[TBL] [Abstract][Full Text] [Related]
11. NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.
Bratasz A; Selvendiran K; Wasowicz T; Bobko A; Khramtsov VV; Ignarro LJ; Kuppusamy P
J Transl Med; 2008 Feb; 6():9. PubMed ID: 18302761
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
Bufan B; Mojsilović S; Vucićević D; Vucević D; Vasilijić S; Balint B; Colić M
Int Immunopharmacol; 2009 Jul; 9(7-8):910-7. PubMed ID: 19341823
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha.
Fiorucci S; Santucci L; Federici B; Antonelli E; Distrutti E; Morelli O; Renzo GD; Coata G; Cirino G; Soldato PD; Morelli A
Aliment Pharmacol Ther; 1999 Mar; 13(3):421-35. PubMed ID: 10102977
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia.
Emanueli C; Van Linthout S; Salis MB; Monopoli A; Del Soldato P; Ongini E; Madeddu P
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2082-7. PubMed ID: 15345513
[TBL] [Abstract][Full Text] [Related]
17. NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function.
Fiorucci S; Mencarelli A; Mannucci R; Distrutti E; Morelli A; del Soldato P; Moncada S
FASEB J; 2002 Oct; 16(12):1645-7. PubMed ID: 12207011
[TBL] [Abstract][Full Text] [Related]
18. Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.
Muzaffar S; Shukla N; Angelini G; Jeremy JY
Circulation; 2004 Aug; 110(9):1140-7. PubMed ID: 15326075
[TBL] [Abstract][Full Text] [Related]
19. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
Chattopadhyay M; Kodela R; Olson KR; Kashfi K
Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect.
Kashfi K; Rayyan Y; Qiao LL; Williams JL; Chen J; Del Soldato P; Traganos F; Rigas B; Ryann Y
J Pharmacol Exp Ther; 2002 Dec; 303(3):1273-82. PubMed ID: 12438552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
